Home

iTeos Therapeutics, Inc. - Common Stock (ITOS)

7.5400
-0.1400 (-1.82%)

Iteos Therapeutics Inc. is a biopharmaceutical company dedicated to advancing the development of innovative cancer therapies

The company focuses on discovering and developing novel immune-oncology treatments that harness the body's immune system to target and fight cancer more effectively. With a strong emphasis on research and development, Iteos aims to create breakthrough medicines that can improve outcomes for patients living with various types of cancers, while also exploring unique mechanisms of action to address unmet medical needs in the oncology space.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is iTeos Therapeutics, Inc. - Common Stock publicly traded?
Yes, iTeos Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does iTeos Therapeutics, Inc. - Common Stock trade on?
iTeos Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for iTeos Therapeutics, Inc. - Common Stock?
The ticker symbol for iTeos Therapeutics, Inc. - Common Stock is ITOS on the Nasdaq Stock Market
What is the current price of iTeos Therapeutics, Inc. - Common Stock?
The current price of iTeos Therapeutics, Inc. - Common Stock is 7.540
When was iTeos Therapeutics, Inc. - Common Stock last traded?
The last trade of iTeos Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of iTeos Therapeutics, Inc. - Common Stock?
The market capitalization of iTeos Therapeutics, Inc. - Common Stock is 269.66M
How many shares of iTeos Therapeutics, Inc. - Common Stock are outstanding?
iTeos Therapeutics, Inc. - Common Stock has 35.76M shares outstanding.